{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:05:04Z","timestamp":1762211104017,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2023-00212125"],"award-info":[{"award-number":["RS-2023-00212125"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurophysiology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.clinph.2025.2110990","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T23:27:50Z","timestamp":1756250870000},"page":"2110990","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Electrophysiological features of anti-neurofascin-155 autoimmune nodopathy: Preferential involvement of distal and proximal segments"],"prefix":"10.1016","volume":"179","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9708-5420","authenticated-orcid":false,"given":"Jinhee","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeon Hak","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MinGi","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee Jo","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5074-1217","authenticated-orcid":false,"given":"Hee-Jae","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyunjin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8047-1029","authenticated-orcid":false,"given":"Eun-Jae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-min","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byoung Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Woo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4408-8265","authenticated-orcid":false,"given":"Ha Young","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clinph.2025.2110990_b0005","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1388-2457(01)00469-2","article-title":"Terminal latency index and modified F ratio in distinction of chronic demyelinating neuropathies","volume":"112","author":"Attarian","year":"2001","journal-title":"Clin. Neurophysiol."},{"issue":"3","key":"10.1016\/j.clinph.2025.2110990_b0010","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1161\/01.STR.0000258355.23810.c6","article-title":"Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis","volume":"38","author":"Banks","year":"2007","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.clinph.2025.2110990_b0015","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/mus.24207","article-title":"INCAT disability score: a critical analysis of its measurement properties","volume":"50","author":"Breiner","year":"2014","journal-title":"Muscle. Nerve."},{"issue":"1","key":"10.1016\/j.clinph.2025.2110990_b0020","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000639","article-title":"Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: clinical relevance of IgG isotype","volume":"7","author":"Cortese","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"12","key":"10.1016\/j.clinph.2025.2110990_b0025","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1007\/s00415-020-10041-z","article-title":"Antibodies against the node of Ranvier: a real-life evaluation of incidence, clinical features and response to treatment based on a prospective analysis of 1500 sera","volume":"267","author":"Delmont","year":"2020","journal-title":"J. Neurol."},{"issue":"7","key":"10.1016\/j.clinph.2025.2110990_b0030","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1093\/brain\/awx124","article-title":"Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy","volume":"140","author":"Delmont","year":"2017","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.clinph.2025.2110990_b0035","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/mus.26010","article-title":"Neurofascin-155 IGG4 neuropathy: pathophysiological insights, spectrum of clinical severity and response to treatment","volume":"57","author":"Garg","year":"2018","journal-title":"Muscle. Nerve."},{"issue":"3","key":"10.1016\/j.clinph.2025.2110990_b0040","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.molmed.2017.01.004","article-title":"Immune regulation of antibody access to neuronal tissues","volume":"23","author":"Iwasaki","year":"2017","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.clinph.2025.2110990_b0045","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jneuroim.2016.10.013","article-title":"IgG4 anti-neurofascin155 antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: clinical significance and diagnostic utility of a conventional assay","volume":"301","author":"Kadoya","year":"2016","journal-title":"J. Neuroimmunol."},{"issue":"Pt 5","key":"10.1016\/j.clinph.2025.2110990_b0050","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/brain\/117.5.941","article-title":"Distal accentuation of conduction slowing in polyneuropathy associated with antibodies to myelin-associated glycoprotein and sulphated glucuronyl paragloboside","volume":"117","author":"Kaku","year":"1994","journal-title":"Brain"},{"key":"10.1016\/j.clinph.2025.2110990_b0055","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.665136","article-title":"Anti-neurofascin 155 antibody-positive chronic inflammatory demyelinating polyneuropathy\/combined central and peripheral demyelination: strategies for diagnosis and treatment based on the disease mechanism","volume":"12","author":"Kira","year":"2021","journal-title":"Front. Neurol."},{"issue":"11","key":"10.1016\/j.clinph.2025.2110990_b0060","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/mus.880141111","article-title":"Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barr\u00e9 syndrome","volume":"14","author":"Kleyweg","year":"1991","journal-title":"Muscle. Nerve."},{"issue":"4","key":"10.1016\/j.clinph.2025.2110990_b0065","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.clinph.2020.01.013","article-title":"Electrophysiological features of chronic inflammatory demyelinating polyradiculoneuropathy associated with IgG4 antibodies targeting neurofascin 155 or contactin 1 glycoproteins","volume":"131","author":"Kouton","year":"2020","journal-title":"Clin. Neurophysiol."},{"issue":"6","key":"10.1016\/j.clinph.2025.2110990_b0070","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1007\/s10072-021-05811-0","article-title":"Frequency and clinical correlates of anti-nerve antibodies in a large population of CIDP patients included in the Italian database","volume":"43","author":"Liberatore","year":"2022","journal-title":"Neurol. Sci."},{"issue":"2","key":"10.1016\/j.clinph.2025.2110990_b0075","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/mus.20678","article-title":"Terminal latency index in neuropathy with antibodies against myelin-associated glycoproteins","volume":"35","author":"Lupu","year":"2007","journal-title":"Muscle. Nerve."},{"issue":"2","key":"10.1016\/j.clinph.2025.2110990_b0080","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3988\/jcn.2023.0055","article-title":"Clinical features of autoimmune nodopathy with anti-neurofascin-155 antibodies in South Koreans","volume":"20","author":"Lyou","year":"2024","journal-title":"J. Clin. Neurol."},{"issue":"6","key":"10.1016\/j.clinph.2025.2110990_b0085","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1172\/JCI124694","article-title":"Anti-Neurofascin-155 IgG4 antibodies prevent paranodal complex formation in vivo","volume":"129","author":"Manso","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.clinph.2025.2110990_b0090","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/acn3.248","article-title":"Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy","volume":"2","author":"Ogata","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"5","key":"10.1016\/j.clinph.2025.2110990_b0095","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/mus.880170504","article-title":"What is the best diagnostic index of conduction block and temporal dispersion?","volume":"17","author":"Oh","year":"1994","journal-title":"Muscle. Nerve."},{"issue":"3","key":"10.1016\/j.clinph.2025.2110990_b0100","first-page":"265","article-title":"Microenvironment of the peripheral nervous system under normal and pathological conditions","volume":"5","author":"Olsson","year":"1990","journal-title":"Crit. Rev. Neurobiol."},{"issue":"12","key":"10.1016\/j.clinph.2025.2110990_b0105","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S1474-4422(16)30231-9","article-title":"Carpal tunnel syndrome: clinical features, diagnosis, and management","volume":"15","author":"Padua","year":"2016","journal-title":"Lancet Neurol."},{"issue":"9","key":"10.1016\/j.clinph.2025.2110990_b0110","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nrneurol.2017.84","article-title":"Autoantibodies in chronic inflammatory neuropathies: diagnostic and therapeutic implications","volume":"13","author":"Querol","year":"2017","journal-title":"Nat. Rev. Neurol."},{"issue":"10","key":"10.1016\/j.clinph.2025.2110990_b0115","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1212\/WNL.0000000000000205","article-title":"Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg","volume":"82","author":"Querol","year":"2014","journal-title":"Neurology"},{"issue":"24","key":"10.1016\/j.clinph.2025.2110990_b0120","doi-asserted-by":"crossref","first-page":"e2392","DOI":"10.1212\/WNL.0000000000012932","article-title":"Neurofascin-155 immunoglobulin subtypes: clinicopathologic associations and neurologic outcomes","volume":"97","author":"Shelly","year":"2021","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.clinph.2025.2110990_b0125","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/micr.1055","article-title":"Development of the blood-nerve barrier in neonatal rats","volume":"21","author":"Smith","year":"2001","journal-title":"Microsurgery"},{"issue":"3","key":"10.1016\/j.clinph.2025.2110990_b0130","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.nmd.2016.10.008","article-title":"Paranodal lesions in chronic inflammatory demyelinating polyneuropathy associated with anti-Neurofascin 155 antibodies","volume":"27","author":"Vallat","year":"2017","journal-title":"Neuromuscul. Disord."},{"issue":"11","key":"10.1016\/j.clinph.2025.2110990_b0135","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1111\/ene.14959","article-title":"European academy of neurology\/peripheral nerve society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force-second revision","volume":"28","author":"Van den Bergh","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.clinph.2025.2110990_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2019.577074","article-title":"Chronic inflammatory demyelinating polyneuropathy with anti-NF155 IgG4 in China","volume":"337","author":"Zhang","year":"2019","journal-title":"J. Neuroimmunol."}],"container-title":["Clinical Neurophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388245725008429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388245725008429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T22:55:58Z","timestamp":1762210558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388245725008429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":28,"alternative-id":["S1388245725008429"],"URL":"https:\/\/doi.org\/10.1016\/j.clinph.2025.2110990","relation":{},"ISSN":["1388-2457"],"issn-type":[{"type":"print","value":"1388-2457"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Electrophysiological features of anti-neurofascin-155 autoimmune nodopathy: Preferential involvement of distal and proximal segments","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinph.2025.2110990","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"2110990"}}